Andersen, N. H., Knudsen, S. T.
, Poulsen, P. L., Poulsen, S. H., Helleberg, K., Eiskjaer, H., Hansen, K. W., Bek, T. & Mogensen, C. E. (2003).
Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design.
Journal of Renin Angiotensin Aldosterone System,
4(2), 96-99.
Andersen, N. H., Knudsen, S. T., Poulsen, P. L., Poulsen, S. H., Helleberg, K.
, Eiskjær, H., Hansen, K. W.
, Bek, T. & Mogensen, C. E. (2003).
Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design.
Journal of the Renin-Angiotensin-Aldosterone System,
4(2), 96-99.
Andersen, N. H., Poulsen, S. H., Helleberg, K., Ivarsen, P., Knudsen, S. T. & Mogensen, C. E. (2003).
Impact of essential hypertension and diabetes mellitus on left ventricular systolic and diastolic performance.
European Journal of Echocardiography,
4(4), 306-312.
Andersen, N. H., Poulsen, S. H., Helleberg, K.
, Ivarsen, P., Knudsen, S. T.
& Mogensen, C. E. (2003).
Impact of essential hypertension and diabetes mellitus on left ventricular systolic and diastolic performance.
European Journal of Echocardiography,
4(4), 306-312.
Bindslev-Jensen, C., Sten, E., Earl, L. K., Crevel, R. W., Bindslev-Jensen, U.
, Hansen, T. K., Stahl Skov, P. & Poulsen, L. K. (2003).
Assessment of the potential allergenicity of ice structuring protein type III HPLC 12 using the FAO/WHO 2001 decision tree for novel foods.
Food and Chemical Toxicology,
41(1), 81-87.
Boger, R. H.
, Frystyk, J., Ledet, T., Møller, N., Flyvbjerg, A. & Ørskov, H. (2003).
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease.
Circulation,
107(20), 193-193.
Boger, R. H.
, Frystyk, J., Ledet, T., Møller, N., Flyvbjerg, A. & Ørskov, H. (2003).
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease.
Circulation,
107(20), 193-193.